MORROW opens Singapore preventive healthcare flagship
Analysis based on 10 articles · First reported Aug 04, 2026 · Last updated Aug 04, 2026
The launch signals growth in the preventive healthcare and longevity sector, potentially attracting investment and consumer spending. MORROW Medical's expansion plans could create new market opportunities in Asia and beyond, though the company is private and not directly listed.
MORROW Medical, a longevity platform founded by Allen Law, opened its 45,000 sq ft Singapore flagship on 4 August 2026. Located within Longevity World, the flagship combines MORROW Medical's diagnostics and medical guidance with MORROW Medical's movement, nutrition, recovery, and coaching services. Backed by US$156 million in committed investment, MORROW Medical plans to expand to more than 10 locations across Asia, Australasia, and the Middle East over five years, targeting over US$230 million in annual revenue. China — Hong Kong is expected to be the next location. The launch highlights the growing economic importance of preventive healthcare, with McKinsey Health Institute estimating US$12.5 trillion in annual economic value by 2050 from scaling preventive interventions.
Set up alerts, explore entity relationships, search across thousands of events, and build custom intelligence feeds.
Open Dashboard